{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:50:26Z","timestamp":1791946226431,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-025-01648-w","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:43Z","timestamp":1762521403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dutch guideline for the prevention and control of multidrug-resistant organisms in the hospital setting, 2024 update"],"prefix":"10.1186","volume":"14","author":[{"given":"Annelotte E.","family":"Sussenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Weterings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Bathoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrte J.","family":"Tielemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"ten Oever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Visch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bergervoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Kluytmans-van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitske","family":"Graveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00ebtte A.","family":"Severin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"10325","key":"1648_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"RC Antimicrobial","year":"2022","unstructured":"Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"1648_CR2","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2022. Stockholm: ECDC; 2023."},{"key":"1648_CR3","unstructured":"European Centre for Disease Prevention and Control. Data on antimicrobial resistance. Surveillance Atlas of Infectious Diseases. 2022."},{"key":"1648_CR4","unstructured":"de Greeff S, Kolwijck E, Schoffelen A. NethMap 2023. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2022\/MARAN 2023. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2022. RIVM; 2023."},{"issue":"5\u20136","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-005-5079-z","volume":"33","author":"MF Kluytmans-Vandenbergh","year":"2005","unstructured":"Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005;33(5\u20136):309\u201313.","journal-title":"Infection"},{"key":"1648_CR6","unstructured":"WIP-richtlijn \u2018Bijzonder resistente micro-organismen (BRMO)\u2019 - hospitals. 2013."},{"key":"1648_CR7","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1016\/S0195-6701(99)90103-2","volume":"43","author":"PJ van den Broek","year":"1999","unstructured":"van den Broek PJ. National guidelines for infection control in The Netherlands. J Hosp Infect. 1999;43:S297\u20139.","journal-title":"J Hosp Infect"},{"key":"1648_CR8","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202412.1391.v1","author":"AE Sussenbach","year":"2024","unstructured":"Sussenbach AE, Versteeg B, Aanhane F, Weijdema K, Graveland H, Voss A. National guidelines for infection prevention and control in the Netherlands. Preprints. 2024. https:\/\/doi.org\/10.20944\/preprints202412.1391.v1.","journal-title":"Preprints"},{"key":"1648_CR9","unstructured":"SRI Richtlijnen. Available from: https:\/\/www.sri-richtlijnen.nl. Accessed on January 22nd 2025."},{"key":"1648_CR10","unstructured":"Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Richtlijn Bijzonder resistente microorganismen 2024 [Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/bijzonder_resistente_micro-organismen_brmo\/startpagina_-_bijzonder_resistente_micro-organismen_brmo.html&nbsp;. Accessed on January 22nd 2025."},{"key":"1648_CR11","first-page":"167","volume":"32","author":"P Alonso-Coello","year":"2017","unstructured":"Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. \"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices 2: Clinical practice guidelines. Gac Sanit. 2017;32:167-e1.","journal-title":"Gac Sanit"},{"key":"1648_CR12","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1136\/bmj.i2016","volume":"353","author":"P Alonso-Coello","year":"2016","unstructured":"Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:2016.","journal-title":"BMJ"},{"issue":"18","key":"1648_CR13","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839\u201342.","journal-title":"CMAJ"},{"key":"1648_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE working group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4\u201313.","journal-title":"J Clin Epidemiol"},{"key":"1648_CR15","unstructured":"Holger Sch\u00fcnemann JB, Gordon Guyatt, Andrew Oxman. GRADE Handbook GRADE handbook for grading quality of evidence and strength of recommendations 2013. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed on January 22nd 2025."},{"issue":"3","key":"1648_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"1648_CR17","unstructured":"World Health Organization. (2017, February 27). WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization."},{"key":"1648_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025. https:\/\/doi.org\/10.1016\/S1473-3099(25)00118-5.","journal-title":"Lancet Infect Dis"},{"key":"1648_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","volume":"77","author":"A Chowdhary","year":"2023","unstructured":"Chowdhary A, Jain K, Chauhan N. Candida auris genetics and emergence. Annu Rev Microbiol. 2023;77:583\u2013602.","journal-title":"Annu Rev Microbiol"},{"issue":"7","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"e0005322","DOI":"10.1128\/aac.00053-22","volume":"66","author":"SE Jacobs","year":"2022","unstructured":"Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D, et al. Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother. 2022;66(7):e0005322.","journal-title":"Antimicrob Agents Chemother"},{"key":"1648_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-17","author":"A Jeffery-Smith","year":"2018","unstructured":"Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018. https:\/\/doi.org\/10.1128\/CMR.00029-17.","journal-title":"Clin Microbiol Rev"},{"issue":"46","key":"1648_CR22","doi-asserted-by":"publisher","first-page":"2200846","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200846","volume":"27","author":"A Kohlenberg","year":"2022","unstructured":"Kohlenberg A, Monnet DL, Plachouras D, Willinger B, Lagrou K, Philipova I, et al. Increasing number of cases and outbreaks caused by Candida auris in the EU\/EEA, 2020 to 2021. Eurosurveillance. 2022;27(46):2200846.","journal-title":"Eurosurveillance"},{"issue":"29","key":"1648_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.15585\/mmwr.mm7029a2","volume":"70","author":"M Lyman","year":"2021","unstructured":"Lyman M, Forsberg K, Reuben J, Dang T, Free R, Seagle EE, et al. Notes from the field: transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities - Texas and the District of Columbia, January-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1022\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1648_CR24","doi-asserted-by":"publisher","first-page":"e0084222","DOI":"10.1128\/mbio.00842-22","volume":"13","author":"LS Burrack","year":"2022","unstructured":"Burrack LS, Todd RT, Soisangwan N, Wiederhold NP, Selmecki A. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo. MBio. 2022;13(4):e0084222.","journal-title":"MBio"},{"issue":"12","key":"1648_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/myc.13655","volume":"66","author":"B Spruijtenburg","year":"2023","unstructured":"Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses. 2023;66(12):1079\u201386.","journal-title":"Mycoses"},{"issue":"4","key":"1648_CR26","doi-asserted-by":"publisher","first-page":"106558","DOI":"10.1016\/j.ijantimicag.2022.106558","volume":"59","author":"A Ceballos-Garzon","year":"2022","unstructured":"Ceballos-Garzon A, Garcia-Effron G, Cordoba S, Rodriguez JY, Alvarez-Moreno C, Pape PL, et al. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK(R)2 results for Candida auris susceptibility testing. Int J Antimicrob Agents. 2022;59(4):106558.","journal-title":"Int J Antimicrob Agents"},{"key":"1648_CR27","unstructured":"Netherlands Society for Microbiology. NVMM Guideline Laboratory detection of highly resistant microorganisms, version 2.0. 2012."},{"issue":"12","key":"1648_CR28","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1128\/JCM.01982-13","volume":"51","author":"F Arena","year":"2013","unstructured":"Arena F, Giani T, Becucci E, Conte V, Zanelli G, D\u2019Andrea MM, et al. Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC beta-lactamase in a neonatal intensive care unit. J Clin Microbiol. 2013;51(12):4067\u201372.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1648_CR29","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1469-0691.2010.03319.x","volume":"17","author":"K Diestra","year":"2011","unstructured":"Diestra K, Miro E, Marti C, Navarro D, Cuquet J, Coll P, et al. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect. 2011;17(7):1032\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1648_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jhin.2005.11.010","volume":"63","author":"S Ohana","year":"2006","unstructured":"Ohana S, Denys P, Guillemot D, Lortat-Jacob S, Ronco E, Rottman M, et al. Control of an ACC-1-producing Klebsiella pneumoniae outbreak in a physical medicine and rehabilitation unit. J Hosp Infect. 2006;63(1):34\u20138.","journal-title":"J Hosp Infect"},{"issue":"10","key":"1648_CR31","doi-asserted-by":"publisher","first-page":"e0204864","DOI":"10.1371\/journal.pone.0204864","volume":"13","author":"E den Drijver","year":"2018","unstructured":"den Drijver E, Verweij JJ, Verhulst C, Oome S, Soer J, Willemsen I, et al. Decline in AmpC beta-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013\u20132016). PLoS ONE. 2018;13(10):e0204864.","journal-title":"PLoS ONE"},{"key":"1648_CR32","unstructured":"Mascini E, Hendrix R, Vos G, Stuart CH namens de regieraad en de permanente Expertgroepen MRSA (meticilline-resistente Staphylococcus aureus) en BRMO van de Werkgroep Infectie Preventie. Correctie in alinea over meldingsplichtig - Alertheid gevraagd voor mogelijk risico van MRSA\/BRMO-dragerschap onder asielzoekers 2015."},{"issue":"9","key":"1648_CR33","doi-asserted-by":"publisher","first-page":"e0222200","DOI":"10.1371\/journal.pone.0222200","volume":"14","author":"E van Dulm","year":"2019","unstructured":"van Dulm E, Tholen ATR, Pettersson A, van Rooijen MS, Willemsen I, Molenaar P, et al. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands. PLoS ONE. 2019;14(9):e0222200.","journal-title":"PLoS ONE"},{"issue":"1","key":"1648_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13756-020-00733-6","volume":"9","author":"AF Voor In \u2018t Holt","year":"2020","unstructured":"Voor In \u2018t Holt AF, Mourik K, Beishuizen B, van der Schoor AS, Verbon A, Vos MC, et al. Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors. Antimicrob Resist Infect Control. 2020;9(1):71.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1648_CR35","doi-asserted-by":"publisher","first-page":"101823","DOI":"10.1016\/j.tmaid.2020.101823","volume":"37","author":"TC Wuerz","year":"2020","unstructured":"Wuerz TC, Kassim SS, Atkins KE. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: systematic review and meta-analysis. Travel Med Infect Dis. 2020;37:101823.","journal-title":"Travel Med Infect Dis"},{"issue":"7","key":"1648_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.medmal.2018.02.005","volume":"48","author":"L Armand-Lefevre","year":"2018","unstructured":"Armand-Lefevre L, Andremont A, Ruppe E. Travel and acquisition of multidrug-resistant Enterobacteriaceae. Med Mal Infect. 2018;48(7):431\u201341.","journal-title":"Med Mal Infect"},{"issue":"7","key":"1648_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/mdr.2022.0035","volume":"28","author":"W Ling","year":"2022","unstructured":"Ling W, Peri AM, Furuya-Kanamori L, Harris PNA, Paterson DL. Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis. Microb Drug Resist. 2022;28(7):795\u2013805.","journal-title":"Microb Drug Resist"},{"issue":"4","key":"1648_CR38","first-page":"174","volume":"30","author":"J Lankelma","year":"2022","unstructured":"Lankelma J, van Mansfeld R. BRMO screening op de (poli) kliniek. MEDISCHE MICROBIOLOGIE. 2022;30(4):174.","journal-title":"MEDISCHE MICROBIOLOGIE"},{"key":"1648_CR39","unstructured":"World Health Organization Clean Care is Safer Care \u2013 tools and resources WHO, Geneva (2009)."},{"issue":"2","key":"1648_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijantimicag.2010.10.014","volume":"37","author":"IK Neonakis","year":"2011","unstructured":"Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents. 2011;37(2):102\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"1648_CR41","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ajic.2016.05.022","volume":"44","author":"Y Yakupogullari","year":"2016","unstructured":"Yakupogullari Y, Otlu B, Ersoy Y, Kuzucu C, Bayindir Y, Kayabas U, et al. Is airborne transmission of Acinetobacter baumannii possible: a prospective molecular epidemiologic study in a tertiary care hospital. Am J Infect Control. 2016;44(12):1595\u20139.","journal-title":"Am J Infect Control"},{"issue":"10","key":"1648_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S1473-3099(19)30262-2","volume":"19","author":"MFQ Kluytmans-van den Bergh","year":"2019","unstructured":"Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls C, de Brauwer E, Buiting AGM, Diederen BM, et al. Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study. Lancet Infect Dis. 2019;19(10):1069\u201379.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1648_CR43","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/cid\/ciy581","volume":"68","author":"A Heinrichs","year":"2019","unstructured":"Heinrichs A, Argudin MA, De Mendonca R, Deplano A, Roisin S, Dodemont M, et al. An outpatient clinic as a potential site of transmission for an outbreak of New Delhi Metallo-beta-Lactamase-producing Klebsiella pneumoniae sequence type 716: a study using whole-genome sequencing. Clin Infect Dis. 2019;68(6):993\u20131000.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1648_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1086\/503174","volume":"27","author":"EA Grabsch","year":"2006","unstructured":"Grabsch EA, Burrell LJ, Padiglione A, O\u2019Keeffe JM, Ballard S, Grayson ML. Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis. Infect Control Hosp Epidemiol. 2006;27(3):287\u201393.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"1648_CR45","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jac\/dkh450","volume":"54","author":"P Kalocheretis","year":"2004","unstructured":"Kalocheretis P, Baimakou E, Zerbala S, Papaparaskevas J, Makriniotou I, Tassios PT, et al. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece. J Antimicrob Chemother. 2004;54(6):1031\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1648_CR46","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1093\/cid\/ciaa1734","volume":"72","author":"S Klein","year":"2021","unstructured":"Klein S, Boutin S, Spath I, Kimmich C, Brandt J, Muller-Tidow C, et al. Acquisition and transmission of carbapenemase-producing (blaKPC-2) Enterobacter cloacae in a highly frequented outpatient clinic. Clin Infect Dis. 2021;72(5):e158\u201361.","journal-title":"Clin Infect Dis"},{"key":"1648_CR47","unstructured":"Srinivasan A Jweble, et al. Practical Healthcare Epidemiology, 3rd ed. Chapter 12 Outbreak Investigations. The Society for Healthcare Epidemiology of America. 2010."},{"issue":"10","key":"1648_CR48","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory C. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10):S165\u201393.","journal-title":"Am J Infect Control"},{"key":"1648_CR49","unstructured":"Mevius D, Heederik D, Duijkeren E, Veldman K, van Essen A, Kant A, et al. Rapport ESBL-Attributieanalyse (ESBLAT): Op zoek naar de bronnen van antibioticaresistentie bij de mens. De Stichting TKI Agri&Food (TKI); 2018."},{"issue":"1","key":"1648_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-023-01350-9","volume":"12","author":"SH Woudt","year":"2023","unstructured":"Woudt SH, Schoffelen AF, Frakking FN, Reuland EA, Severin JA, den Drijver M, et al. Description of a nationwide structure for monitoring nosocomial outbreaks of (highly resistant) microorganisms in the Netherlands: characteristics of outbreaks in 2012\u20132021. Antimicrob Resist Infect Control. 2023;12(1):143.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"1648_CR51","doi-asserted-by":"publisher","first-page":"e0211016","DOI":"10.1371\/journal.pone.0211016","volume":"14","author":"D Souverein","year":"2019","unstructured":"Souverein D, Euser SM, Herpers BL, Kluytmans J, Rossen JWA, Den Boer JW. Association between rectal colonization with highly resistant gram-negative rods (HR-GNRs) and subsequent infection with HR-GNRs in clinical patients: a one year historical cohort study. PLoS ONE. 2019;14(1):e0211016.","journal-title":"PLoS ONE"},{"issue":"2","key":"1648_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhin.2010.04.027","volume":"76","author":"C Abad","year":"2010","unstructured":"Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect. 2010;76(2):97\u2013102.","journal-title":"J Hosp Infect"},{"issue":"2","key":"1648_CR53","doi-asserted-by":"publisher","first-page":"e0246820","DOI":"10.1371\/journal.pone.0246820","volume":"16","author":"S Bushuven","year":"2021","unstructured":"Bushuven S, Dettenkofer M, Dietz A, Bushuven S, Dierenbach P, Inthorn J, et al. Interprofessional perceptions of emotional, social, and ethical effects of multidrug-resistant organisms: a qualitative study. PLoS ONE. 2021;16(2):e0246820.","journal-title":"PLoS ONE"},{"issue":"3","key":"1648_CR54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmi.2018.10.007","volume":"25","author":"B Rump","year":"2019","unstructured":"Rump B, Timen A, Verweij M, Hulscher M. Experiences of carriers of multidrug-resistant organisms: a systematic review. Clin Microbiol Infect. 2019;25(3):274\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1648_CR55","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/jac\/dkw221","volume":"71","author":"H Bar-Yoseph","year":"2016","unstructured":"Bar-Yoseph H, Hussein K, Braun E, Paul M. Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(10):2729\u201339.","journal-title":"J Antimicrob Chemother"},{"key":"1648_CR56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1471-2334-14-177","volume":"14","author":"ES Shenoy","year":"2014","unstructured":"Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis. 2014;14:177.","journal-title":"BMC Infect Dis"},{"key":"1648_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13756-018-0390-5","volume":"7","author":"B Davido","year":"2018","unstructured":"Davido B, Moussiegt A, Dinh A, Bouchand F, Matt M, Senard O, et al. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality? Antimicrob Resist Infect Control. 2018;7:100.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"32","key":"1648_CR58","doi-asserted-by":"publisher","first-page":"e26913","DOI":"10.1097\/MD.0000000000026913","volume":"100","author":"HE Choi","year":"2021","unstructured":"Choi HE, Lee JH, Sim YJ, Jeong HJ, Kim GC. Predictors of prolonged vancomycin-resistant enterococci colonization in acute stroke patients admitted to an intensive care unit: a retrospective cohort study. Medicine (Baltimore). 2021;100(32):e26913.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1648_CR59","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00134-014-3225-8","volume":"40","author":"MR Haverkate","year":"2014","unstructured":"Haverkate MR, Derde LP, Brun-Buisson C, Bonten MJ, Bootsma MC. Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med. 2014;40(4):564\u201371.","journal-title":"Intensive Care Med"},{"issue":"10","key":"1648_CR60","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ajic.2021.06.006","volume":"49","author":"A Jimenez","year":"2021","unstructured":"Jimenez A, Fennie K, Munoz-Price LS, Ibrahimou B, Pekovic V, Abbo LM, et al. Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: a retrospective cohort study. Am J Infect Control. 2021;49(10):1281\u20136.","journal-title":"Am J Infect Control"},{"issue":"10","key":"1648_CR61","doi-asserted-by":"publisher","first-page":"1104e5","DOI":"10.1016\/j.cmi.2018.05.013","volume":"24","author":"YJ Lim","year":"2018","unstructured":"Lim YJ, Park HY, Lee JY, Kwak SH, Kim MN, Sung H, et al. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE. Clin Microbiol Infect. 2018;24(10):1104e5-e8.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1648_CR62","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cmi.2017.12.028","volume":"24","author":"V Nordberg","year":"2018","unstructured":"Nordberg V, Jonsson K, Giske CG, Iversen A, Aspevall O, Jonsson B, et al. Neonatal intestinal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae-a 5-year follow-up study. Clin Microbiol Infect. 2018;24(9):1004\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1648_CR63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3855\/jidc.4451","volume":"8","author":"H Gedik","year":"2014","unstructured":"Gedik H, Yildirmak T, Simsek F, Kanturk A, Arica D, Aydin D, et al. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies. J Infect Dev Ctries. 2014;8(9):1113\u20138.","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"1648_CR64","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ajic.2016.03.032","volume":"44","author":"DM Lister","year":"2016","unstructured":"Lister DM, Tan K, Carse E, Stuart RL. Clearance of infant vancomycin-resistant Enterococcus faecium carriage after a neonatal inpatient outbreak. Am J Infect Control. 2016;44(10):1172\u20133.","journal-title":"Am J Infect Control"},{"issue":"4","key":"1648_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcgg.2015.11.002","volume":"7","author":"D Miu","year":"2016","unstructured":"Miu D, Ling S, Tse C. Epidemiology of vancomycin-resistant enterococci in postacute care facility and predictors of clearance: a 5-year retrospective cohort study. J Clin Gerontol Geriatr. 2016;7(4):153\u20137.","journal-title":"J Clin Gerontol Geriatr"},{"issue":"42","key":"1648_CR66","doi-asserted-by":"publisher","first-page":"30376","DOI":"10.2807\/1560-7917.ES.2016.21.42.30376","volume":"21","author":"I Overdevest","year":"2016","unstructured":"Overdevest I, Haverkate M, Veenemans J, Hendriks Y, Verhulst C, Mulders A, et al. Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands 2013 to 2014. Euro Surveill. 2016;21(42):30376.","journal-title":"Euro Surveill"},{"issue":"4","key":"1648_CR67","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.ijid.2012.09.019","volume":"17","author":"KM Sohn","year":"2013","unstructured":"Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17(4):e240\u20136.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1648_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13756-022-01132-9","volume":"11","author":"V Weterings","year":"2022","unstructured":"Weterings V, van den Bijllaardt W, Bootsma M, Hendriks Y, Kilsdonk L, Mulders A, et al. Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents s2013\u20132019). Antimicrob Resist Infect Control. 2022;11(1):98.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1648_CR69","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2147\/IDR.S361013","volume":"15","author":"W Wangchinda","year":"2022","unstructured":"Wangchinda W, Laohasakprasit K, Lerdlamyong K, Thamlikitkul V. Epidemiology of carbapenem-resistant enterobacterales infection and colonization in hospitalized patients at a University Hospital in Thailand. Infect Drug Resist. 2022;15:2199\u2013210.","journal-title":"Infect Drug Resist"},{"key":"1648_CR70","unstructured":"NVMM. Richtlijn Laboratoriumdetectie bijzonder resistente micro-organismen (BRMO). 2021."},{"issue":"2","key":"1648_CR71","first-page":"61","volume":"30","author":"E Meijer","year":"2022","unstructured":"Meijer E, Voss A, Meis J. Candida auris: huidige inzichten. Ned Tijdschr Med Microbiol. 2022;30(2):61.","journal-title":"Ned Tijdschr Med Microbiol"},{"issue":"12","key":"1648_CR72","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ajic.2013.04.018","volume":"41","author":"I Oren","year":"2013","unstructured":"Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control. 2013;41(12):1167\u201372.","journal-title":"Am J Infect Control"},{"key":"1648_CR73","unstructured":"Sinnige JC WR, Ruijs GJHM, Mascini E, Arends JP, Troelstra A. NVMM Guideline HRMO VRE. 2015."},{"issue":"7","key":"1648_CR74","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1128\/JCM.00258-17","volume":"55","author":"JM Fonville","year":"2017","unstructured":"Fonville JM, van Herk CMC, Das P, van de Bovenkamp JHB, van Dommelen L. A single negative result for van quantitative PCR on enrichment broth can replace five rectal swab cultures in screening for vancomycin-resistant enterococci. J Clin Microbiol. 2017;55(7):2261\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1648_CR75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jhin.2015.02.017","volume":"90","author":"A Mitchell","year":"2015","unstructured":"Mitchell A, Spencer M, Edmiston C Jr. Role of healthcare apparel and other healthcare textiles in the transmission of pathogens: a review of the literature. J Hosp Infect. 2015;90(4):285\u201392.","journal-title":"J Hosp Infect"},{"key":"1648_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jac\/48.suppl_1.87","volume":"48","author":"DM Livermore","year":"2001","unstructured":"Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother. 2001;48:87\u2013102.","journal-title":"J Antimicrob Chemother"},{"key":"1648_CR77","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fmicb.2018.00828","volume":"9","author":"L Sandner-Miranda","year":"2018","unstructured":"Sandner-Miranda L, Vinuesa P, Cravioto A, Morales-Espinosa R. The genomic basis of intrinsic and acquired antibiotic resistance in the genus Serratia. Front Microbiol. 2018;9:828.","journal-title":"Front Microbiol"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:03:34Z","timestamp":1762524214000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01648-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}